NSC |
Compound |
Enrichment |
Correlation |
NSC 112846 |
N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid |
0.0179905510964914 |
0.59389699 |
NSC 128687 |
6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) |
0.0179905510964914 |
0.33287528 |
NSC 144310 |
4H-Thiopyran-4-one, 3,5-bis[(3,4-dimethoxyphenyl) methylene]-tetrahydro- |
0.0179905510964914 |
0.25608877 |
NSC 236580 |
.beta.-Alanine, N-[N-[N-[N-[1-(D-2-hydroxy-4-methyl-1-oxopentyl)-L-prolyl]-L-isoleucyl]-N-methyl-L-valyl]-N-methyl-L-alanyl]-, .rho.-lactone |
0.0179905510964914 |
0.38736214 |
NSC 328785 |
ANTINEOPLASTIC-328785 |
0.0179905510964914 |
0.39194732 |
NSC 348977 |
1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)ethylidene]hydrazide, dihydrochloride |
0.0179905510964914 |
0.3356618 |
NSC 359463 |
Null |
0.0179905510964914 |
0.36960653 |
NSC 361667 |
Null |
0.0179905510964914 |
-0.16650222 |
NSC 409304 |
Null |
0.0179905510964914 |
0.43926449 |
NSC 634766 |
Null |
0.0179905510964914 |
0.30206445 |